期刊文献+

法莫替丁定时释放小丸的释药机制 被引量:3

Drug release mechanism of famotidine time-controlled release pellets
下载PDF
导出
摘要 目的研究法莫替丁定时释放小丸的释药机制,初步探索有机酸诱导型给药系统的释药机制。方法从离子交换反应、水化作用等方面分别研究了琥珀酸离子和琥珀酸分子在药物释放过程中的作用。结果琥珀酸酸根离子通过与膜材进行离子交换反应造成了新的离子环境,琥珀酸分子由于进入膜材的疏水部分而提高了膜的柔韧性。上述两种作用均可导致膜水化作用增强,从而使膜的透过性明显增加。结论定时释放小丸的时滞是由于膜材的疏水性所致;当水进入丸芯溶解有机酸后,产生的酸根离子及有机酸分子以不同的方式与膜材发生相互作用,显著提高了其透过性,从而使药物快速释放出来。 Aim To study the drug release mechanism of famotidine time-controlled release pellets and to explore the mechanism of "organic acid-induced type drug delivery system". Methods The effects of dissociated and undissociated forms of succinic acid on the drug release behavior of famotidine timecontrolled release pellets were studied from the following aspects: ion-exchange reaction, hydration, etc. Results The dissociated succinic acid created new ionic circumstances by ion-exchange reaction with Eudragit RS100. Whereas undissociated succinic acid increased the flexibility of the film by distribution in the hydrophobic segment of Eudragit RS100. Effects of both forms of the succinic acid could improve the hydration of Eudragit RS film. As a result, the permeability of the film was improved evidently. Conclusion The lag time of famotidine time-controlled release pellets is induced by the hydrophobicity of the film. After water dissolve the organic acid, the dissociated and undissociated forms of succinic acid interact with the film through different ways. These interactions can change the structure of the film. Therefore the permeability of the film will be improved markedly.
出处 《药学学报》 CAS CSCD 北大核心 2006年第9期873-877,共5页 Acta Pharmaceutica Sinica
关键词 法莫替丁 定时释放小丸 有机酸诱导型释药系统 famotidine time-controlled release pellet organic acid-induced type drug delivery system
  • 相关文献

参考文献2

二级参考文献1

  • 1Bodmeier R,Pharmaceut Res,1996年,13卷,1期,52页

共引文献26

同被引文献26

  • 1张彦,张志荣.硫酸特布他林脉冲控释片的制备与释放机理研究[J].药学学报,2003,38(11):854-858. 被引量:8
  • 2Kshirsagar SJ, S. V. Patil and M. R. Bhalekar, Statistical optimization of floating pulsatile drug delivery system for chronotherapy of hypertension [ J ]. Int J Pharm lnvestig, 2011 ;1(4) :207-213.
  • 3Elliott WJ, Ram cvs. Calcium channel blockers [ J ]. The Journal of Clinical Hpertension ,2011 ;9 ( 13 ) :687-689.
  • 4Schmltz P, Kleinebudde P. A new multi- particulate de- layedrelease system. Part 1 :dissolution properties and releasemechanism [ J ]. J Controlled Release, 1997 ; 47 (2) :181.
  • 5Narisaw S, Nagata M, Hirakawa Y. An organic acid- induced sigmoidal release system for oral controlled- release preparation m elucidation of the anomalous drug release behavio through osmotic pumping mechanism[ J. Int J Pharm, 1997 ;148( 1 ) :852-855.
  • 6Roland Bodmeier,Xiaodi Guo,Rafael E. Sarabia,Paul F. Skultety.The Influence of Buffer Species and Strength on Diltiazem HC1 Release from Beads Coated with the Aqueous Cationic Polymer Dispersions, Eudragit RS, RL 30D[J].Pharmaceutical Research.1996(1)
  • 7Shinji Narisawa,Minako Nagata,Chieko Danyoshi,Hiroyuki Yoshino,Kazuo Murata,Yoshiyuki Hirakawa,Kazuo Noda.An Organic Acid-Induced Sigmoidal Release System for Oral Controlled-Release Preparations[J].Pharmaceutical Research.1994(1)
  • 8匡玉霞,付晓琴,刘生友.高血压病的最佳给药时间探讨[J].中国药师,2008,11(9):1113-1114. 被引量:6
  • 9薛立安,李元波,郭丹丹,殷建华,刘晏春,侯世祥.复方丹参泡腾性渗透泵片的制备及释药机制研究[J].中国中药杂志,2009,34(7):848-851. 被引量:13
  • 10林朝霞,张芳向.硫酸沙丁胺醇哮喘时辰治疗药的制备及其体外释放度[J].中国医药导报,2009,6(24):43-45. 被引量:1

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部